Press release: Online availability of Sanofi’s half-year financial report for 2025

Core Viewpoint - Sanofi has made its half-year financial report for 2025 available, which has been filed with the French market regulator and submitted to the U.S. SEC [1][2]. Company Overview - Sanofi is an R&D driven, AI-powered biopharma company focused on improving lives and delivering growth through innovative medicines and vaccines [3]. - The company leverages its understanding of the immune system to create treatments that benefit millions globally, with a commitment to addressing urgent healthcare, environmental, and societal challenges [3]. - Sanofi is publicly listed on EURONEXT and NASDAQ [3].